SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Reports that Papa Johns largest U.S. franchisee has joined Irth Capitals take-private effort are driving buyout speculation. Traders see the franchisees involvement as strengthening the bid, while others remain skeptical the board will accept a deal given its past decisions and the companys weak operating performance.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

A sharp XCN price spike, with traders citing a large candle and a sizable short-term gain but no clear news catalyst, is driving attention. The community is split between buying the dip and expecting a rebound, and warning that the recurring pumps quickly fade into sell-offs.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens Phase 3 DeLLphi-305 results for IMDELLTRA plus AstraZenecas IMFINZI in first-line small-cell lung cancer are driving attention, with traders highlighting the reported survival benefit and potential to expand IMDELLTRAs role. The community is weighing that pipeline opportunity against Repathas established sales growth as a key near-term business driver.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is drawing attention after a rally tied to the PHP2Shell web-server vulnerabilities, which prompted concern about widespread attacks and potential demand for Cloudflares WAF and traffic-protection services. Traders are framing the security scare as a possible business tailwind, while some focus on the sharp move and question whether it can continue.

Palo Alto Networks, is a cybersecurity company that provides cybersecurity platforms and services to enterprises, organizations, service providers, and government entities. Its offerings include network and AI security, cloud security, security operations, and identity security solutions. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is rallying with cybersecurity peers as AI-related security concerns and newly publicized vulnerabilities reinforce expectations for stronger enterprise security spending; traders also point to a bullish channel-partner survey suggesting budgets are firming. The move has drawn bullish momentum trading, while some investors question whether elevated valuations already reflect that demand.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

ESMO subgroup analyses from Celcuitys Phase 3 VIKTORIA-1 study are driving discussion, with traders highlighting favorable results for the gedatolisib triplet in PIK3CA-mutant breast cancer; the topline findings had been reported previously. Reactions are largely encouraged by the data, while some traders argue the stock still needs proof of commercial sales and execution, and the timing of an FDA label-expansion decision remains uncertain.

Sony Group Corp. engages in the development, design, manufacture, and sale of electronic equipment, instruments, devices, game consoles, and software for consumers, professionals and industrial markets. It operates through the following segments: Game and Network Services, Music, Pictures, Entertainment Technology & Services, Imaging and Sensing Solutions, Financial Services, and Others. The Game and Network Services segment deals with gaming machines, software and network services. The Music segment produces and publishes music and provides image media platforms. The Pictures segment handles film production, television program creation, and media networks. The Home Entertainment and Sound segment offers LCD televisions, home audio, Blu-ray Disc players and recorders, and memory-based portable audio devices. The Imaging and Sensing Solutions segment includes the image sensors business. The Financial Services segment manages the life insurance and non-life insurance operations and banking business. The Others segment consists of various operating activities, including the disc manufacturing and recording media businesses. The company was founded by Akio Morita and Masaru Ibuka on May 7, 1946 and is headquartered in Tokyo, Japan.

Sony Group Corporation - ADR

Sony Group Corporation

Sonys plan to stop producing physical PlayStation game discs for new releases from 2028 is driving debate, with critics warning that losing resale and ownership options could push players away from PlayStation, while supporters argue a digital shift could improve margins. Traders are split on whether the move is a long-term business benefit or a risk to console demand and customer loyalty.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEOs sale of its Adelanto ICE facilities to DHS, followed by debt repayment and greater flexibility for share buybacks, dominates the discussion. Bulls see the transaction as strengthening the balance sheet and supporting shareholder returns, while others question why the stock weakened and worry about the implications of selling facilities for future operations.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTechs BNT113 cancer-immunotherapy trial missed its first primary endpoint of progression-free survival, though overall-survival analysis is ongoing. Traders are debating whether that setback and leadership concerns outweigh other oncology-pipeline signals, including pumitamig data; Modernas melanoma-vaccine success is also shaping comparisons between the companies.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

IEPs sharp selloff has traders debating its distributions sustainability and the companys financial outlook, including portfolio and hedging losses and debt concerns. Some blame short-selling or speculate about a cut, while bullish traders point to IEPs CVR Energy stake and hope for stronger cash returns; no single confirmed catalyst dominates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026

Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026 Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026PR NewswireFRIENDSWOOD, Texas, Oct. 15, 2026FRIENDSWOOD, Texas, Oct. 15, 2026...

ACG 2026 Data Show TissueCypher Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus

ACG 2026 Data Show TissueCypher Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus ACG 2026 Data Show TissueCypher Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's EsophagusPR NewswireFRIENDSWOOD, Texas, Oct. 12, 2026Studies...

Late-Breaking EADV 2026 Data Support Use of DecisionDx-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management

Late-Breaking EADV 2026 Data Support Use of DecisionDx-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management Late-Breaking EADV 2026 Data Support Use of DecisionDx-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical ManagementPR NewswireFRIENDSWOOD, Texas, Sept. 30...

New Study Shows That TissueCypher Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus

New Study Shows That TissueCypher Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus New Study Shows That TissueCypher Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's EsophagusPR...

Castle Biosciences to Open New Laboratory Facility in Scottsdale

Castle Biosciences to Open New Laboratory Facility in Scottsdale Castle Biosciences to Open New Laboratory Facility in ScottsdalePR NewswireFRIENDSWOOD, Texas, Sept. 22, 2026 New 55,000-square-foot facility expands Castle's operational footprint in Arizona to support growing test volumes and...

New Decision Modeling Study Demonstrates TissueCypher Significantly Improves Risk-Aligned Management for Patients with Barrett's Esophagus

New Decision Modeling Study Demonstrates TissueCypher Significantly Improves Risk-Aligned Management for Patients with Barrett's Esophagus New Decision Modeling Study Demonstrates TissueCypher Significantly Improves Risk-Aligned Management for Patients with Barrett's EsophagusPR...

JAAD Publication Shows Improved Performance of DecisionDx-SCC

JAAD Publication Shows Improved Performance of DecisionDx-SCC JAAD Publication Shows Improved Performance of DecisionDx-SCC PR Newswire FRIENDSWOOD, Texas, Sept. 9, 2026 DecisionDx-SCC shows enhanced performance with the integration of select clinicopathologic risk factors, providing a more precise...

SciBase receives additional order from Castle Biosciences, advancing the collaboration

SciBase receives additional order from Castle Biosciences, advancing the collaboration SciBase receives additional order from Castle Biosciences, advancing the collaboration PR Newswire STOCKHOLM, Sept. 8, 2026 STOCKHOLM, Sept. 8, 2026 /PRNewswire/ -- SciBase Holding AB("SciBase") (STO: SCIB), a...

Castle Biosciences, Inc. (CSTL) Is Up 15.46% in One Week: What You Should Know 

Does Castle Biosciences, Inc. (CSTL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Does Castle Biosciences (CSTL) Have the Potential to Rally 31.46% as Wall Street Analysts Expect?

The consensus price target hints at a 31.5% upside potential for Castle Biosciences (CSTL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Castle Biosciences, Inc. is a molecular diagnostics company, which offers innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.

Castle Biosciences Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$33.08
Prev Close	$33.19
Open	$33.41
Dividend Yield	0.00%
50-Day Moving Average	$33.69
Beta	0.99
Avg. Volume	347,605.94
PE Ratio	-50.86

52-Week High	$44.28
52-Week Low	$17.72
Market Capitalization	$1.01B
EPS (Annual)	-$0.8334
Price to Book	2.15
Revenue Per Employee	$389,840.32

Feed

News

Sentiment

Earnings

Fundamentals

Info

CSTL Fundamentals